Trends in antimicrobial resistance in Campylobacter spp. causing traveler's diarrhea

APMIS

Volumn 115, Issue 3, 2007, Pages 218-224

  Ruiz, Joaquim ^a   Marco, Francesc ^b   Oliveira, Ines ^b   Vila, Jordi ^b   Gascón, Joaquim ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Campylobacter; Quinolones; Resistance; Traveler's diarrhea

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; MACROLIDE; NALIDIXIC ACID; NORFLOXACIN; PENICILLIN G; QUINOLONE DERIVATIVE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CAMPYLOBACTER; CONTROLLED STUDY; FISHER EXACT TEST; HUMAN; MAJOR CLINICAL STUDY; MANTEL HAENSZEL TEST; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TRAVELLER DIARRHEA; TREATMENT FAILURE; TREATMENT INDICATION;

ANTI-BACTERIAL AGENTS; CAMPYLOBACTER; CAMPYLOBACTER INFECTIONS; DIARRHEA; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; SPAIN; TRAVEL; TROPICAL CLIMATE;

EID: 33947268751     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2007.apm_567.x     Document Type: Article

References (25)

1. Bartoloni A, Cutts F, Leoni S, Austin CC, Mantella A, Guglielmetti P, et al. Patterns of antimicrobial use and antimicrobial resistance among healthy children in Bolivia. Trop Med Int Health 1998;3:116-23.
2. Hart CA, Kariuki S. Antimicrobial resistance in developing countries. BMJ 1998;317:647-50.
3. Radyowijati A, Haak H. Improving antibiotic use in low-income countries: an overview of evidence on determinants. Soc Sci Med 2003;57:733-44.
4. Castelli F, Pezzoli C, Tomasoni L. Epidemiology of traveler's diarrhea. J Travel Med 2001;8 (Suppl):S26-30.
5. Okhuysen PC. Current concepts in travelers' diarrhea: epidemiology, antimicrobial susceptibility and treatment. Curr Opin Infect Dis 2005;18:522-6.
6. Svenungsson B, Lagergren A, Ekwall E, Evengard B, Hedlund KO, Karnell A, et al. Enteropathogens in adult patients with diarrhea and healthy control subjects: a 1-year prospective study in a Swedish clinic for infectious diseases. Clin Infect Dis 2000;30:770-8.
7. Allos BM. Campylobacter jejuni infections: update on emerging issues and trends. Clin Infect Dis 2001;32:1201-6.
8. Cabrera R, Ruiz J, Arroyo M, Marco F, Oliveira I, Aladueña A, et al. Characterization of the mechanisms of resistance to several antimicrobial agents in Salmonella clinical isolates causing of traveler's diarrhea. Antimicrob Agents Chemother 2004;48:3934-9.
9. Hakanen A, Jousimies-Somer H, Siitonen A, Huovinen P, Kotilainen P. Fluoroquinolone resistance in Campylobacter jejuni isolates in travelers returning to Finland: association of ciprofloxacin resistance to travel destination. Emerg Infect Dis 2003;9:267-70.
10. Vila J, Vargas M, Ruiz J, Espasa M, Pujol M, Corachan M, et al. Susceptibility patterns of enteroaggregative Escherichia coli associated with traveller's diarrhoea: emergence of quinolone resistance. J Med Microbiol 2001;50:996-1000.
11. Merson MH, Morris GK, Sack DA, Wells JG, Feeley JC, Sack RB, et al. Travelers' diarrhea in Mexico. A prospective study of physicians and family members attending a congress. N Engl J Med 1976; 294: 1299-305.
12. Ruiz J, Goñi P, Marco F, Gallardo F, Mirelis B, Jimenez de Anta T, et al. Increased resistance to quinolones in Campylobacter jejuni: a genetic analysis of gyrA gene mutations in quinolone-resistant clinical isolates. Microbiol Immunol 1998;42:223-6.
13. Murray, PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of Clinical Microbiology, 6th ed. Washington, D.C.: ASM Press, 1995.
14. Vargas M, Gascon J, Gallardo F, Jimenez de Anta MT, Vila J. Prevalence of diarrheagenic Escherichia coli strains detected by PCR in patients with travelers' diarrhea. Clin Microbiol Infect 1998;4:682-8.
15. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Supplement. M100-S14. Wayne, PA, NCCLS, 2004.
16. Cardinale E, Dromigny JA, Tall F, Ndiaye M, Konte M, Perrier-Gros-Claude JD. Fluoroquinolone susceptibility of Campylobacter strains, Senegal. Emerg Infect Dis 2003; 9: 1479-81.
17. Pazhani GP, Ramamurthy T, Mitra U, Bhattacharya SK, Niyogi SK. Species diversity and antimicrobial resistance of Shigella spp. isolated between 2001 and 2004 from hospitalized children with diarrhoea in Kolkata (Calcutta), India. Epidemiol Infect 2005;133:1089-95.
18. Boonmar S, Bangtrakulnonth A, Pornruangwong S, Samosornsuk S, Kaneko K, Ogawa M. Significant increase in antibiotic resistance of Salmonella isolates from human beings and chicken meat in Thailand. Vet Microbiol 1998;62:73-80.
19. Sur D, Ramamurthy T, Deen J, Bhattacharya SK. Shigellosis: challenges & management issues. Indian J Med Res 2004;120:454-62.
20. Adler-Mosca, H, Luthy-Hottenstein J, Martinetti Lucchini G, Burnens A. Altwegg AM. Development of resistance to quinolones in five patients with campylobacteriosis treated with norfloxacin or ciprofloxacin. Eur J Clin Microbiol Infect Dis 1991;10:953-7.
21. Kuschner RA, Trofa AF, Thomas RJ, Hoge CW, Pitarangsi C, Amato S, et al. Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent. Clin Infect Dis 1995;21:536-41.
22. Ruiz J, Moreno A, Jimenez de Anta MT, Vila J. A double mutation in the gyrA gene is necessary to produce high levels of resistance to moxifloxacin in Campylobacter spp. clinical isolates. Int J Antimicrob Agents 2005;25:542-5.
23. Wagner J, Jabbusch M, Eisenblatter M, Hahn H, Wendt C, Ignatius R. Susceptibilities of Campylobacter jejuni isolates from Germany to ciprofloxacin, moxifloxacin, erythromycin, clindamycin and tetracycline. Antimicrob Agents Chemother 2003;47:2358-61.
24. Ruiz J. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA Gyrase protection. J Antimicrob Chemother 2003;51:1109-17.
25. Saenz Y, Ruiz J, Zarazaga M, Teixidó M, Torres C, Vila J. Effect of the efflux pump inhibitor Phe-Arg-β-naphthylamide on the MIC values of the quinolones, tetracycline and chloramphenicol, in Escherichia coli isolates of different origin. J Antimicrob Chemother 2004;53:544-5.